Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemay005 in Moderate to Severe Plaque Psoriasis
CTR20210660Phase 3Completed
- Sponsor
- Hainan Hailing
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mufemilast in psoriasis, sponsored by Hainan Hailing. Started Dec 2021; status: completed.
02
Drugs
mufemilast
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20210660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210660.